The antitrust trial against Live Nation Entertainment and Ticketmaster is nearing its end, with a lawyer for 34 states arguing that the company monopolizes the concert industry and inflates prices. Live Nation's lawyer countered, stating that the company's success is due to hard work and that the market is more competitive than ever. Jurors are expected to begin deliberations soon after closing arguments concluded.

Alpha Modus Holdings (AMOD) is exchanging 3,870,000 Series C preferred shares for over 109 million Class A common shares with CEO William Alessi's family trust. This equity restructuring aims to boost the company’s market value and reduce its stockholders’ deficit. The move comes as a response to an April 6, 2026 Nasdaq notice indicating that Alpha Modus no longer meets minimum listing standards.

Federal regulators ordered a dozen New England utilities to refund $1.5 billion to ratepayers, citing overcharges on transmission projects dating back to 2011. However, the utilities, led by Eversource and Avangrid, are pushing back, requesting more time to process the refunds and asking for a complete stay on the order pending legal appeals. They argue that a forced refund could harm their credit ratings, increase borrowing costs, and lead to "rate whiplash" for consumers.

Allogene Therapeutics, Inc. announced it will host a conference call and webcast on Monday, April 13, 2026, to review interim futility analysis data from its pivotal Phase 2 ALPHA3 trial. This trial evaluates cemacabtagene ansegedleucel (cema-cel) in first-line consolidation large B-cell lymphoma (LBCL). The company, a clinical-stage biotechnology firm, specializes in developing allogeneic CAR T products for cancer and autoimmune diseases.

Rollins Inc. (US7757111049) leads the U.S. pest control market with a recurring revenue model driven by essential services, making it a resilient investment tied to American consumer spending and real estate. The company's strategy focuses on organic growth, strategic acquisitions, and technological integration within a growing market influenced by urbanization and climate change. Analysts view Rollins as a high-quality compounder with defensive growth, though risks like weather volatility, labor shortages, and regulatory changes require monitoring.

Humana Inc. (HUM) announced the appointment of Robert Field to its Board of Directors, a strategic move to enhance its healthcare sector expertise. Field, principal of nMed Capital Management, brings significant experience in healthcare services investments. The company, a major U.S. health insurer, holds a P/E ratio of 19.55 and a GF Score of 70/100, indicating solid performance with strong growth potential despite areas for financial strength improvement.

Zspace Inc. has launched a new augmented and virtual reality platform designed to provide immersive STEM and career learning experiences without requiring headsets. This technology aims to make hands-on, interactive education more accessible and engaging for students. The company positions its solution as a significant advancement in educational technology, enhancing practical learning in science, technology, engineering, and mathematics for schools and institutions.

AT&T's core wireless and broadband businesses are crucial for its revenue, with significant investments in its 5G network. The company's strategic focus on connectivity and streamlined operations aims to provide stability and returns for U.S. investors, making it a defensive holding. However, it faces risks from intense competition, high debt, and regulatory scrutiny.

Snap's new XR subsidiary, Specs Inc., has formed a multi-year strategic partnership with Qualcomm to power its next-generation AR glasses with Snapdragon XR chips. This collaboration, building on over five years of work, emphasizes on-device AI for more natural, private, and context-aware AR experiences. The partnership provides Specs Inc. a technical edge and reliable silicon supply, while Qualcomm gains a design win in the growing AR eyewear segment, aiming to move AR from niche applications to mainstream consumer use.

Grupo Aeroméxico will host its Q1 2026 earnings call on April 22, 2026, at 10:30 a.m. Mexico City Time to discuss operating and financial performance. The company will release its Q1 earnings results after market close on April 21, 2026. A live webcast and replay will be available for investors and analysts to review the key business drivers and strategic initiatives.